Clinical Trial

Intranasal Insulin to Prevent Intensive Care Unit Delirium

Name: Intranasal Insulin to Prevent Intensive Care Unit Delirium — clinical trial record (NCT07532577)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: INSPIRE

Completed Phase 2/3

View on ClinicalTrials.gov →

Summary

This study aims to assess the feasibility, tolerability, and exploratory efficacy of intranasal insulin to prevent delirium in ICU patients aged ≥65 years after complex elective cardiac surgery with cardiopulmonary bypass

Protocol Amendment History 1 change

critical Completed without a posted recruiting period 2026-08-04

Trial Details

NCT Number	NCT07532577
Lead Sponsor	Radboud University Medical Center
Conditions	Delirium - Postoperative
Enrollment	30 participants
Start Date	2026-04-30
Primary Completion	2026-07-15 (estimated)
Study Completion	2026-07-30 (estimated)
Updated on ClinicalTrials.gov	2026-08-03